CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0552
(Tag F0552)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, the facility failed to ensure one resident (#32) and/or...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, the facility failed to ensure one resident (#32) and/or their representative was informed of the risks and benefits of psychotropic medications prior to administration. The sample size was 20. The deficient practice could result in residents and/or their representatives not being fully informed of the risks, benefits and alternatives to proposed treatment.
Findings include:
-Resident #32 admitted to the facility on [DATE] with diagnoses including chronic respiratory failure with hypoxia, chronic obstructive pulmonary disease and post traumatic seizures.
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 15 on the Brief Interview for Mental Status (BIMS) assessment, indicating intact cognition. The resident reported no feelings of depression, and he displayed no symptoms of psychosis or behaviors.
A physician ' s order dated 11/30/22 revealed quetiapine fumarate (antipsychotic) 25 mg (milligrams): give one tablet at bedtime for traumatic brain injury (TBI).
Review of the November 30, 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
The December 1 through 6, 2022 MAR revealed the resident received antipsychotic medication per orders.
A psychotropic medication care plan dated 12/06/22 related to (traumatic brain injury) TBI had a goal for the resident to be/remain free from psychotropic drug-related complications. Interventions included to administer psychotropic medications as ordered by the physician. Monitor for side effects and effectiveness every shift.
However, an informed consent relating to the risks and benefits of quetiapine fumarate was not identified in the resident's clinical record until 12/07/22.
Another physician's order dated 12/12/22 included fluoxetine HCl (antidepressant) 20mg: give one capsule by mouth in the morning for depression.
Review of the December 13 through 31, 2022 MAR revealed the resident received the antidepressant in accordance with the physician ' s orders.
However, an informed consent relating to the risks and benefits of fluoxetine HCl was not identified in the resident's clinical record until 01/04/23.
On 01/11/23 at 8:41 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #6). She stated that once an order is obtained for psychotropic medication, nursing will explain the risks and benefits of the medication, alternatives to drug therapy and non-pharmacologic interventions. She stated that if the resident was alert and oriented x4, she would obtain the consent from the resident. If they can give verbal consent, she will complete an e-signed consent for them. She stated that the consent would be added to the resident's medical record instantaneously. She stated that the e-consent does not require two witnesses for a verbal consent from the resident.
An interview was conducted on 01/11/23 at 1:10 p.m. with the Director of Nursing (DON/staff #41). She stated that the provider will explain the risks and benefits of psychotropic medications to the resident prior to administration of the medication. She stated that nursing staff would be responsible for education and obtaining the consent after that.
The Psychotropic Medication Use Policy, revised 11/28/16, included the facility should comply with the psychopharmacologic dosage guidelines created by the Centers for Medicare and Medicaid Services (CMS), the State Operations Manual, and all other applicable law relating to the use of psychopharmacologic medications including gradual dose reductions. Facility staff should inform the resident and/or representative of the initiation, reason for use, and the risks associated with the use of psychotropic medications, per facility policy or applicable state regulations.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0578
(Tag F0578)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and policy and procedure, the facility failed to ensure an advanced directive...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and policy and procedure, the facility failed to ensure an advanced directive was accurate for one resident (#54). The sample size was 20. The deficient practice could result in residents ' wishes not being honored.
Findings include:
Resident #54 admitted to the facility [DATE] with diagnoses that included Alzheimer ' s disease with late onset, dementia in other diseases classified elsewhere, without behavioral, psychotic, or mood disturbance and major depressive disorder, recurrent, in remission.
An admission progress note dated [DATE] at 3:27 p.m. included that the resident had been admitted via medical transport.
An Advanced Directive Statement dated [DATE] revealed the resident ' s directive included cardiopulmonary resuscitation measures (CPR), artificial hydration, hospitalization, antibiotic therapy, and pain medication. The resident signed the directive herself on [DATE]. A facility representative witnessed the directive on the same date.
A Prehospital Medical Care Directive dated [DATE] revealed a Do Not Resuscitate (DNR) status. The document was noted with the resident ' s electronic signature which was time stamped at 4:33 p.m. The document was signed by a Licensed Practical Nurse (LPN/staff #59) at 4:32 p.m. and witnessed by an LPN (staff #32.) The witness statement acknowledged that the signer was present when the directive was signed (or marked) and that the resident/responsible party appeared to be of sound mind and free from duress. The electronic signature was time stamped at 4:32 p.m.
A physician ' s order dated [DATE] included for DNR status.
The admission Minimum Data Set assessment dated [DATE] revealed the resident scored 5 on the Brief Interview for Mental Status, indicating severe cognitive impairment.
An interview was conducted on [DATE] at 11:37 a.m. with an LPN (staff #97). She stated that the admitting nurse provides education regarding an advance directive. She reviewed both advanced directives and stated that if the resident were to code, she would consider her a DNR. She stated that the provider had ordered a DNR.
On [DATE] at 1:58 p.m. an interview was conducted with the Director of Nursing (DON/staff #41) and a Clinical Resource representative (staff #117). Staff #41 stated that an advance directive was completed upon admission. She stated that no nursing documentation would be expected when education was provided to the resident and/or their representative. She stated that they just attempt to get a declaration. She stated that if the resident is not alert and oriented, the responsible party would be contacted and the request would be made. She stated that was her expectation. She reviewed the advance directive signed by the resident and stated that the document would be honored, that it was a viable document. The DNR designation was reviewed and she stated that if the resident ' s advance directive election had changed, there should be documentation to indicate that was the case. She stated that once a discrepancy was identified, she would expect the nurse to reach out to the family/representative and ask them to clarify. Staff #117 stated that it did not meet the expectation for a nurse to have made the code designation.
The Advanced Healthcare Directives Policy, revised 08/19, included that it is the policy of the facility to recognize the right of individuals to control decisions related to his/her medical care. This includes the right to consent, to refuse or to alter treatment plans and formulate advanced directives. Advanced directives executed in accordance with the applicable state law will be honored by the facility. At the time of admission, the Admissions Director/designee must determine whether a resident has executed an advanced directive or has given other instructions to indicate what care he/she desires in case of subsequent incapacity. The admitting nurse is responsible for documenting in the resident ' s medical record the discussion and any advanced directive that the resident executes, including the Arizona Prehospital Medical Care Directive (orange sheet). If a resident is incapacitated at the time of admission and is unable to receive information or articulate whether or not he or she has executed an advanced directive, the facility may give the information to the resident ' s representative in accordance with state law. As long as an individual is competent and able to communicate, he/she will make their own decisions.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0582
(Tag F0582)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interviews, policy review and CMS regulations, the facility failed to ensure that one resident (#5...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interviews, policy review and CMS regulations, the facility failed to ensure that one resident (#56) received a timely Advanced Beneficiary Notification, within 48-hours, for termination of part A Medicare services.
Findings include:
Resident #56 was admitted to the facility on [DATE] with diagnoses that included Unspecified Dementia, Major Depressive Disorder-recurrent / moderate, and Primary insomnia.
Review of the MDS (Minimum Data Set) for resident #56, dated December 4, 2022, revealed a BIMS (Brief Interview of Mental Status) score of 01, indicating severe cognitive impairment.
Record review of the nursing progress notes revealed that resident #56 remained in the facility on private pay after termination of Medicare Part A services.
On January 10, 2023 at 2:01 pm a form, SNF (Skilled Nursing Facility) Beneficiary Protection Notification Review, was provided by the facility. The form included Part A services last covered day was on December 7, 2022. Per the document, the notice was signed via verbal signature on December 8, 2022 by the Director of Social Services.
Further record review revealed no evidence that resident #56 received Advanced Beneficiary Notification or Notice of Medicare Non-Coverage timely.
Review of the nursing progress notes from December 2022 through January 2023 did not reveal information regarding Advanced Beneficiary Notification or Notice of Medicare Non-Coverage.
Further record review revealed no documentation that an Advanced Beneficiary Notification or Notice of Medicare Non-Coverage had been discussed or signed.
An in-person interview was conducted on January 11, 2023 at 9:00 am, with staff # 54 DOSS (Director of Social Services). She stated that the process for the Advanced Beneficiary Notification, included resident notification 2 to 3 days prior to end of services. Staff would document in notes, if they are unable to reach the representative.
An in-person follow-up interview was conducted with staff # 54 (Director of Social Services) on January 11, 2023 at 11:32 am. She stated, with a telephonic ABN, social service staff can sign on behalf of the representative, without a witnessed signature. She stated, the untimely Advanced Beneficiary Notice for resident # 56 was an oversight.
An in-person interview was conducted on January 11, 2023 at 12:30 pm with the administrator, staff # 65 (Administrator). He stated that the Advanced Beneficiary Notice and the Notice of Medicare Non-Coverage are reviewed with residents and or representatives, 48-hours prior to end of skilled services. The stated identified risk is non-payment for the resident's stay. He stated, notes regarding notification review and signature is not required, per the facility guidelines but is best practices.
A review of the facility policy that was revised in 2022, revealed that 2 days prior to end of skilled services, the facility will issue a Notice of Medicare Non-Coverage. The policy states that an Advanced Beneficiary Notice will be issued when a Medicare Part A stay will end and that the facility is expected to maintain compliance with Medicare Beneficiary Notices per CMS (Centers for Medicare and Medicaid Services) guidelines.
Further record review revealed no documentation that an Advanced Beneficiary Notification or Notice of Medicare Non-Coverage had been discussed or signed.
An in-person interview was conducted on January 11, 2023 at 9:00 am, with staff # 54 DOSS (Director of Social Services). She stated that the process for the Advanced Beneficiary Notification, included resident notification 2 to 3 days prior to end of services. Staff would document in notes, if they are unable to reach the representative.
An in-person follow-up interview was conducted with staff # 54 (Director of Social Services) on January 11, 2023 at 11:32 am. She stated, with a telephonic ABN, social service staff can sign on behalf of the representative, without a witnessed signature. She stated, the untimely Advanced Beneficiary Notice for resident # 56 was an oversight.
An in-person interview was conducted on January 11, 2023 at 12:30 pm with the administrator, staff # 65 (Administrator). He stated that the Advanced Beneficiary Notice and the Notice of Medicare Non-Coverage are reviewed with residents and or representatives, 48-hours prior to end of skilled services. The stated identified risk is non-payment for the resident's stay. He stated, notes regarding notification review and signature is not required, per the facility guidelines but is best practices.
A review of the facility policy that was revised in 2022, revealed that 2 days prior to end of skilled services, the facility will issue a Notice of Medicare Non-Coverage. The policy states that an Advanced Beneficiary Notice will be issued when a Medicare Part A stay will end and that the facility is expected to maintain compliance with Medicare Beneficiary Notices per CMS (Centers for Medicare and Medicaid Services) guidelines.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
PASARR Coordination
(Tag F0644)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on review of clinical records, staff interviews and review of facility policy and procedure, the facility failed to ensure...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on review of clinical records, staff interviews and review of facility policy and procedure, the facility failed to ensure that an updated pre-admission screening and resident review (PASRR) was completed for one resident (#14). The deficient practice could lead to residents not receiving needed care and services.
Findings include:
Resident #14 was admitted [DATE] with diagnoses to include the primary diagnosis of Covid 19 and secondary diagnoses of schizoaffective disorder bipolar type, bipolar II disorder, generalized anxiety disorder, major depressive disorder and dementia with other behavior disturbance. The diagnosis of dementia is listed as having an onset of October 1, 2022. All the diagnoses were present upon admission.
Review of the clinical record revealed a completed level 1 PASRR dated October 10, 2012. The level 1 PASRR revealed that the resident had serious mental illness and a level 2 PASRR should be completed.
A letter dated October 19, 2012 from the PASRR coordinator revealed that that the resident was found to have a primary diagnosis of dementia at that time. The letter revealed that the PASRR coordinator should be made aware of any significant changes with the residents medical or psychiatric conditions.
No evidence of any further PASRR documentation was found in the resident clinical record.
Review of her minimum data set (MDS) dated [DATE] revealed that the resident scored a 5 on her brief interview for mental status (BIMS) indicating severe cognitive impairment. The diagnoses of non-Alzheimer's dementia, anxiety disorder, depression, bipolar disorder and schizophrenia were listed as active diagnoses on the MDS.
A Physicians progress note dated January 9, 2023 revealed that the following problems were reviewed:
Schizoaffective disorder - Onset: 09/29/2022
Schizoaffective disorder, bipolar type - Onset: 02/28/2020
Moderate recurrent major depression - Onset: 02/06/2019
Bipolar II disorder - Onset: 10/03/2018
Generalized anxiety disorder - Onset: 06/03/2021
An interview was conducted with the Social Services Director (SSD/ staff# 54) and the Director of Nursing (DON/ staff #41) on January 11, 2023 at 9:18 AM. Staff #54 stated that she and the DON were responsible to complete the PASRR process for the facility. She stated that updated level 1 PASRR's were completed with the help of the DON. If no update is required, the existing PASRR provided by the hospital of transferring facility would be uploaded in to the residents record. Staff #54 stated that she did not know the requirements for PASRR. She stated that she was aware that the DON reviewed the PASRR that was present on resident admission.
The DON/Staff #41 stated that a level 1 PASRR should be done annually. She further stated that resident #14's paperwork had not been updated since 2012 and this does not meet the requirement for PASRR. She stated that she was not aware that a PASRR was to be done annually until very recently. She also stated that a new PASRR should be completed with any new mental health diagnoses. This resident not only has not had a new PASRR since her original admission in 2012 but she has also had several new mental health diagnoses since her readmission in 2018 which required a new PASRR. The DON stated that the current PASRR for resident #14 does not meet the facility requirement for PASRR's.
Review of the facility policy Pre- admission Screening and Resident Review (PASRR. 2020) revealed that the facility was responsible to make referrals for a Level II PASRR. The policy further revealed that an updated PASRR Level I screening must be conducted for each resident in the facility who had a serious mental illness not less than annually.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0657
(Tag F0657)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Regarding Resident #56
Findings include:
-Resident #56 was admitted to the facility on [DATE] with diagnoses that included unspe...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Regarding Resident #56
Findings include:
-Resident #56 was admitted to the facility on [DATE] with diagnoses that included unspecified dementia with other behavior disturbances, major depressive disorder, and primary insomnia.
Review of admission nursing assessment dated [DATE] at 2:11 p.m., stated no open lesion on skin. However, in another section of the assessment included a note which stated the resident had a small scab on the chin. Further review of the assessment did not include measurement or assessment of the scab.
Review of the facility form, Total Body Skin Assessment, dated December 9, 16, 20, 2022 and January 6, 2023 stated resident has no new wounds.
Review of physician order dated January 2, 2023 stated to schedule an appointment for patient with a dermatologist for evaluation and treatment of the wound on the chin. However, record review revealed no evidence that the appointment has been set up.
On January 9, 2023 at 12:12 p.m., during an observation rounds, resident #56 was observed with a wound to her chin.
Review of nursing progress notes dated January 9, 2022 at 4:20 PM, stated the resident had an abrasion/sore on her chin that she picks at.
Review of the resident's comprehensive care plan did not include the actual impairment to skin integrity related to the wound on the chin.
Review of medication and treatment administration records dated December 2022, and January 2023, revealed no evidence of treatment for the wound on the chin.
A second observation of resident #56 was conducted on January 12, 2023 at 8:05 a.m. Resident #56 was in the dining room sitting in the chair with no unusual behavior exhibited. She had a dime-sized wound on her chin, partially covered with a reddish/brownish scab. The surrounding tissue of the wound was reddened with scant amount of dried blood.
A follow up interview was conducted with a certified nursing assistant (CNA/ staff #113) who was present in the dining room. Staff #113 stated she was familiar with resident #56 and that the wound on the resident's chin was almost healed but the resident picked on it. Staff #113 stated she keeps the resident's nails short and clean to help minimize the skin damage on her chin.
An interview was conducted on January 12, 2023 at 8:18 a.m. with a licensed practical nurse (LPN/staff #97). She stated she was familiar with resident #56 and that the resident is independent with activities of daily living (ADLs), ambulatory using a walker. This staff member also stated the resident is awake most of the night. Staff #97 stated the wound/scab on the resident's chin was present during transfer from another unit. The wound heals then come back because she picks on it constantly, almost every day. She stated she redirected the resident and keeps the nails short, but the resident does not remember. The LPN stated she did not include the wound on the chin during the weekly skin assessment because it was not a new wound. She stated the wound on the chin was already present when the resident was transferred from another unit.
Record review revealed no documentation of resident's behavior or care plan related to the changing status of the wound on the chin.
Following staff #97's interview, it was noted that the resident's picture was placed by the entrance of her room. In the picture, it was noted that a scab (a size of a grain of rice) was present on resident's chin.
An interview was conducted with a registered nurse consultant (RN/staff #117) on January 12, 2023 at 2:06 p.m. She stated that her expectation when a wound is identified or changing, the nursing staff must notify the physician and monitor the size weekly. Staff #117 stated the care plan for the wound should be developed at the time the wound is identified.
The Care Plans, Comprehensive Person-Centered policy revised December 2016, included a comprehensive, person-centered care plan that includes measurable objectives and timetables to meet resident ' s physical, psychosocial and functional needs is developed and implemented for each resident. Assessments of residents are ongoing and care plans are revised as information about the residents and the resident's conditions change.
Based on clinical record review, staff interviews and review of policy, the facility failed to ensure two residents (#51 and #56) care plans were updated/revised to meet their changing needs. The sample size was 20. The deficient practice could result in inadequate care and/or not meeting the needs of the resident.
Findings include:
-Resident #51 admitted to the facility 12/20/21 with diagnoses including paroxysmal atrial fibrillation, hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease and rheumatoid arthritis.
The admission Nursing Review dated 12/20/21 at 4:16 p.m. revealed the resident had no pressure sores, and that his skin was intact.
Review of the Baseline Care Plan dated 12/20/21 at 4:44 p.m. included potential for skin breakdown/pressure ulcers due to decreased mobility and incontinence. No goal or interventions were identified in the plan of care.
A potential risk for pressure ulcer development care plan initiated on 01/09/22 related to immobility had a goal for the resident to have intact skin, free of redness, blisters or discoloration. Interventions included to follow facility policies/protocols for the prevention/treatment of skin breakdown.
The significant change MDS assessment dated [DATE] revealed the resident scored 7 on the brief interview for mental status, indicating severe cognitive impairment. He required extensive one-person physical assistance for most activities of daily living, including bed mobility, and he had no pressure ulcers/injuries.
A Skin & Wound Evaluation dated 02/02/22 revealed a facility acquired deep tissue injury (DTI) to the resident's right lateral thigh. The wound measured at 1.7 centimeters (cm) x 2.2 cm. The wound bed was described as epithelial, 100% of wound covered, surface intact. Additional care included alternating pressure mattress and pressure reduction wheelchair cushion, nutrition/dietary supplementation and assistance with repositioning every 2 hours and as needed (PRN).
Review of the potential risk for pressure ulcer development care plan dated 02/02/22 revealed an update to include a deep tissue injury to the resident ' s right thigh. The goal was for the resident's pressure ulcer to show signs of healing and remain free from infection. Interventions included to assess/record/monitor wound healing every week.
The dietary progress note dated 02/04/22 at 6:44 p.m. included that the resident received 4 ounces of oral nutritional supplements 4 times per day with 100% intake. The note indicated that current meal and supplement intakes combined appeared to be meeting the estimated energy needs for wound healing.
The Skin & Wound Evaluation dated 02/18/22 revealed a deteriorating unstageable pressure ulcer which measured 3.9 cm x 2.8 cm. The wound bed was described as 80% slough, with light serosanguineous exudate, the edges were noted as epithelialization with blanching and erythema of the surrounding tissue. Additional care remained the same.
Review of the resident's potential risk for pressure ulcer development care plan did not include updated or revised interventions to address the changing wound status.
Review of the Skin & Wound Evaluation dated 03/07/22 revealed a deteriorating unstageable pressure ulcer measuring 4.6 cm x 2.3 cm, with 90% of the wound bed filled with slough. Light serosanguineous exudate was noted, with edges identified as epithelialization with blanching and erythema of the surrounding tissue. Additional care remained the same.
The Skin & Wound Evaluation dated 03/18/22 included a deteriorating unstageable pressure ulcer measuring 4.2 cm x 2.6 cm x 0.5 cm with 100% of the wound bed filled with slough. The wound exhibited warmth, and no exudate was identified. Wound edges were defined as epithelialized and surrounding tissue identified as blanching. The peri-wound temperature was described as warm. Additional care remained the same.
A physician ' s order dated 03/21/22 included cephalexin capsule (antibiotic) 500 milligrams (mg): give 1 capsule two times a day for wound infection for 5 days.
Further review of the resident's care plan did not reveal implementation of additional interventions or revisions to reflect the resident's changing needs.
On 01/11/23 at 9:01 a.m. an interview was conducted with the Assistant Director of Nursing/wound nurse (staff #109). She stated that pressure ulcer interventions include a pressure reduction mattress, and if the resident is at high risk for developing wounds an overlay will be ordered, pressure relieving boots and dietary review. She stated that the facility does not have a repositioning program. She stated that per policy and PRN, every resident will receive a pressure-reduction cushion. She stated that if a resident developed a pressure ulcer, the care plan would be updated to reflect that. She stated that the care plan would be updated and revised if there were any wound changes, if it was resolved, or if there was a new wound classification.
An interview was conducted on 01/11/23 at 1:27 p.m. with the Director of Nursing (DON/staff #41). She stated that when a resident has a new pressure ulcer they bring it to a stand-up meeting and the physician is notified. She stated that a new pressure ulcer/pressure injury would trigger for care planning. She stated that a change in wound status would not necessarily trigger new interventions in the care plan if the interventions that were in place were still appropriate.
The Care Plans, Comprehensive Person-Centered policy revised December 2016, included a comprehensive, person-centered care plan that includes measurable objectives and timetables to meet resident's physical, psychosocial and functional needs is developed and implemented for each resident. Assessments of residents are ongoing and care plans are revised as information about the residents and the resident's condition change.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, the facility failed to ensure one resident (#183) did n...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, the facility failed to ensure one resident (#183) did not receive oxygen without a physician ' s order. The sample size was 20. The deficient practice may increase the risk for residents to receive unnecessary medications.
Findings include:
Resident #183 was readmitted to the facility on [DATE] with pleural effusion, not elsewhere classified, acute and chronic respiratory failure with hypoxia and acute on chronic diastolic (congestive) heart failure.
A baseline care plan dated 03/09/22 included oxygen related to difficulty breathing with increased activity related to effects of congestive heart failure, chronic obstructive pulmonary disease, pneumonia, etc. The goals included to maintain a normal breathing pattern as evidenced by non-labored respirations, normal skin color, and regular respiratory rate/pattern and to maintain a pulse oximetry level at or above 90%.
Physician's orders dated 03/09/22 included albuterol sulfate hydro fluoroalkane aerosol solution (bronchodilator) 108 (90 base) mcg (microgram)/act (actuate). Inhale 2 puffs orally every hour as needed for shortness of breath/wheezing and for oxygen saturation levels were to be obtained in the morning.
The physician's orders did not include administration of oxygen.
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 14 on the Brief Interview for Mental Status, indicating intact cognition. The resident required extensive one-person physical assistance with most activities of daily living and she received oxygen prior to admission, while not residing in the facility.
Review of the Oxygen Saturation Summary dated March 2022 revealed the resident received oxygen for more than 20 days. The resident ' s oxygen saturation rates were above 90% in all instances.
The April 2022 Oxygen Saturation Summary revealed the resident received oxygen for 2 days. The resident's oxygen saturation rates were above 90% on both dates.
On 01/13/23 at 8:09 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #103). She stated that oxygen administration requires a doctor's order, unless the nurse is being proactive in an acute situation. She stated that it would not be appropriate to use the oxygen on a regular basis without an order.
An interview was conducted on 01/13/23 at 9:57 a.m. with the Director of Nursing (DON/staff #41). She stated that a physician ' s order should be obtained prior to administration of oxygen, unless it was an emergent situation. She stated that it would not meet her expectation for oxygen to be administered for several weeks prior to obtaining an order. She stated that risks of administering oxygen unnecessarily would include retention of carbon dioxide and worsening of the medical condition. She stated that it did not meet her expectations.
The Medication and Treatment Orders Policy, revised April 2014, included orders for medications and treatments will be consistent with principles of safe and effective order writing. Medications shall be administered only upon the written order of a person duly licensed and authorized to prescribe such medications in this state. This includes standing orders.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0661
(Tag F0661)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interview, and review of facility policy, the facility failed to ensure that a discharge summary f...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, staff interview, and review of facility policy, the facility failed to ensure that a discharge summary for one resident (#3) contained a recapitulation of the resident's stay and all pre and post discharge medications.
Findings include:
-Resident #3 was admitted on [DATE] with diagnosis that included COVID-19, traumatic subarachnoid hemorrhage, periprosthetic fracture around internal prosthetic right knee joint, hypertensive chronic disease with stage 1 through stage 4, and type 2 diabetes mellitus.
Review of the physician order summary revealed an order for occupational therapy and physical therapy 5 times a week for eight weeks starting September 29, 2022 for therapeutic exercises and gait training.
A 5-day MDS (Minimum Data Set) assessment dated [DATE] revealed a BIMS (Brief Interview of Mental Status) score of 11, indicating moderately impaired cognition. The assessment included that the resident required extensive physical assistance from two staff members for transfer, bed mobility, toilet use, and one-person physical assistance with personal hygiene, and dressing.
Review of nursing progress notes dated November 10, 2022 at 1:00 p.m., stated resident required minimum physical assistance with bed mobility, transfer, supine to sitting position, and sitting to standing position. The note included the resident required stand by assistance with hygiene, and supervision with wheelchair mobility.
Review of a provider Discharge summary dated [DATE] at 12:00 a.m., stated discharge planning for possible discharge to home tomorrow (December 30, 2022). The provider notes included patient is currently under long-term care, compliant with medications and cooperative with nursing care. Further, the notes stated the resident is discharging home with her daughter and that discharge instruction was provided.
A nursing progress notes dated December 30, 2022 at 2:39 p.m., stated the patient was discharged home with daughter. The notes included discharge instruction/medications were reviewed to patient and daughter.
Further record review revealed no evidence of nursing discharge instruction that contained a recapitulation of the resident's stay and the list of all pre and post discharge medications.
On January 10, 2023 at 8:00 a.m., a document request for the Discharge summary dated [DATE] was requested from the facility.
The facility failed to provide evidence of the nursing discharge instruction/summary that contained a recapitulation of the resident's stay and the list of all pre and post discharge medications.
An interview was conducted with a registered nurse consultant (RN/staff #117) on January 12, 2023 at 2:06 p.m. She stated that her expectation included nursing staff to complete a discharge summary including the reconciliation of all pre and post medications. Staff #117 stated if the discharge summary and medications reconciliation is not completed, there is no continuity of care and the resident might not get the medication they needed. She stated if a discharge summary is not completed, the resident maybe at risk of missing the required follow up services.
On January 13, 2023 at 2:30 p.m., a policy for discharge summary and discharge process were requested. The facility failed to provide the policies requested.
According to CMS (Center for Medicare and Medicaid Services) regulations §483.21(c)(2) Discharge Summary, the following must be included: a recapitulation of the resident's stay, reconciliation of all pre-discharge and post-discharge medications, a post -discharge plan of care that is developed with the participation of the resident, and a final summary of the resident's status at the time of discharge.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Quality of Care
(Tag F0684)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, revealed the facility failed to ensure one resident (#5...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy, revealed the facility failed to ensure one resident (#56) received treatment and services in accordance with professional standards of practice. The deficient practice could result in resident not receiving the treatment based on their assessed need.
Findings include:
-Resident #56 was admitted to the facility on [DATE] with diagnoses that included unspecified dementia with other behavior disturbances, major depressive disorder, and primary insomnia.
Review of admission nursing assessment dated [DATE] at 2:11 p.m., stated no open lesion on skin. However, in another section of the assessment included a note which stated the resident have a small scab on the chin. Further review of the assessment did not include measurement or assessment of the scab.
A physician progress note dated September 15, 2022 at 9:00 a.m., stated the resident has a facial lesion on the chin that does not heal, acute, that it could be cancer or just a lesion. The note included the physician assured the nurse it does not need to be biopsied or removed.
Further record review revealed no further diagnostic assessment to support the physician's diagnoses.
Review of the facility form, Total Body Skin Assessment, dated December 9, 16, 20, 2022 and January 6, 2023 stated resident has no new wounds.
A physician note dated December 17, 2022 at 1:35 p.m., stated the resident has a lesion on the chin area that has been present for several weeks and doesn't heal.
A record review revealed no additional assessment or physician notification of the changing wound on the resident's chin.
Review of physician order dated January 2, 2023 stated to schedule an appointment for patient with a dermatologist for evaluation and treatment. However, record review revealed no evidence that the appointment has been set up.
On January 9, 2023 at 12:12 p.m., during an observation rounds, resident #56 was observed with a wound on her chin.
Review of nursing progress notes dated January 9, 2023 at 4:20 PM, stated the resident have an abrasion/sore on chin that she picks at.
Review of medication and treatment administration records dated January 2023, revealed no evidence of treatment for the wound on the chin.
Further record review revealed no assessment and no physician notification of the changing wound status on the resident's chin.
A second observation of resident #56 was conducted on January 12, 2023 at 8:05 a.m. Resident #56 was in the dining room sitting in the chair with no unusual behavior exhibited. She has a dime sized wound on her chin, partially covered with a reddish/brownish scab. The surrounding tissue of the wound was reddened with scant amount of dried beige crust.
A follow up interview was conducted with a certified nursing assistant (CNA/ staff #113) who was present in the dining room. Staff #113 stated she was familiar with resident #56 and that the wound on the resident's chin was almost healed but the resident picked at it.
An interview was conducted on January 12, 2023 at 8:18 a.m. with a licensed practical nurse (LPN/staff #97). She stated she was familiar with the resident, and that the wound/scab on the resident's chin was present when she was transferred from another unit. The LPN stated she did not include the wound on the chin during the weekly skin assessment because it was not a new wound. She stated the wound on the chin was already present when the resident was transferred from another unit.
Further record review revealed no nursing documentation, no assessment and no physician notification of the changing wound on the chin.
Following staff #97's interview, it was noted that there was a picture of the resident on the entrance of her door. On the picture, the resident has a scab on the chin the size of a grain of rice.
An interview was conducted with a registered nurse consultant (RN/staff #117) on January 12, 2023 at 2:06 p.m. She stated that her expectation when a wound is identified or if they are changing, the nursing staff must notify the physician and monitor the size weekly.
A facility policy, Skin/Wound Care Protocol, with a review dated May 2014, included the goal of a preventative skin program is to maintain skin integrity and provide guidelines for skin care. The procedure included all residents are assessed for risk of skin breakdown within 24 hours of admission, and a nurse will complete and document a total body skin assessment. The procedure stated a narrative nurse's documentation will include skin color, blisters, scabs, breaks or sores on the skin and pain or swelling anywhere on the body. Further, the procedure stated a licensed nurse completes a weekly skin assessment and documents the assessment on the weekly skin/pain assessment form which becomes a part of the resident's permanent clinical record.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0685
(Tag F0685)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, clinical record review, staff interviews, and policy, the facility failed to ensure one resident (#54) wa...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, clinical record review, staff interviews, and policy, the facility failed to ensure one resident (#54) was provided assistance with obtaining audiology services. The sample size was 20. The deficient practice may contribute to the resident ' s confusion and agitation.
Findings include:
Resident #54 admitted to the facility on [DATE] with diagnoses including Alzheimer ' s disease, dementia in other diseases classified elsewhere and major depressive disorder.
An admission Nursing Review dated 07/06/21 revealed the resident had impaired hearing.
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 5 on the Brief Interview for Mental Status (BIMS) assessment, indicating severe cognitive impairment. The resident was assessed to have minimal difficulty hearing and that she displayed no behavioral symptoms towards herself or others.
A communication problem care plan initiated 08/03/21 related to a hearing deficit had a goal for the resident to maintain her current level of communication function by responding to yes or no questions. Interventions included to anticipate and meet the resident ' s needs.
A nursing progress note dated 05/13/22 at 12:21 p.m. included that the resident was alert and oriented to person and place (x2) with intermittent confusion. The note indicated that the resident was severely hard of hearing and that she could become very agitated at times related to her hearing impairment.
A nursing progress note dated 10/06/22 at 2:39 p.m. included that the resident had returned from an appointment with an ear, nose and throat (ENT) provider. Per the note, no new orders had been received and a follow-up appointment was recommended in one year. The note stated that the ENT did give a referral for hearing aid assistance and that the information was given to social services for follow-up.
However, a review of the clinical record did not provide evidence that the resident had been provided an appointment for hearing aid evaluation or services.
A physician note dated 10/27/22 at 12:28 p.m. included that upon interview that day, the resident was laying in bed, was verbal with clear speech. The note indicated that the resident was Spanish speaking and that a translator was assisting. Per the note, staff reported that the resident was hard of hearing and had trouble understanding what was being asked and that she responded with nonsense.
The annual MDS assessment dated [DATE] revealed the resident scored 10 on the BIMS assessment, indicating moderate cognitive impairment. The resident was assessed to have moderate difficulty hearing and she displayed behavioral symptoms directed towards others and directed towards herself for 1 to 3 days in the 7 day look-back period.
On 01/12/23 at 11:37 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #97). She stated that the resident had just come back from an ENT appointment. She stated that she did not know whether or not there had been a follow-up scheduled. She stated she had not asked the resident whether or not she would like a follow-up appointment. She stated that she had spoken about the resident obtaining hearing aids with another nurse and that they did not know whether the resident would keep them in or not. She stated that she did not know whether anyone had spoken to the resident about hearing aids.
An interview was conducted on 01/12/23 at 1:58 p.m. with the Director of Nursing (DON/staff #41). She stated that at any point, she would expect nursing to notify the provider regarding the necessity for audiology services, She stated that she would anticipate that services would be coordinated with Hospice, the case manager and social services so that the resident could maintain her highest level of function. She stated that she thought that the interdisciplinary team and the resident ' s representative should have been involved. She stated that it should have been reviewed quarterly in the quarterly care conferences. She stated that issues with hearing could be contributing to agitation and confusion. She stated services should have been coordinated by everybody.
On 01/13/23 at 8:59 a.m. an interview was conducted with the Director of Social Services (staff #54). She stated that ultimately, she was responsible to ensure that residents are getting annual hearing, dental and vision appointments. She stated that if an emergent situation were to arise, she would also arrange an appointment as needed. She stated that if the residents were not getting their appointments it would be because either she had not set one up or the resident had refused. She stated that the lack of dental services had been an error on her part.
The Informing Residents of Health, Medical Condition and Treatment Options policy, revised December 2016, included that residents will be informed of their health, medical condition and options for treatment and/or care. The resident ' s Attending Physician, the facility ' s Medical Director, or the Director of Nursing Services will be responsible for informing the resident of his or her medical condition. Such information will include providing the resident with information, including his/her sensory and physical impairments, type of care or treatment recommended (based on the assessment and care plan), type of professional who will be providing the care or treatment and treatment alternatives or options.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Pressure Ulcer Prevention
(Tag F0686)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record reviews, observations, staff interviews, facility documentation, and policy and procedures, the facilit...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record reviews, observations, staff interviews, facility documentation, and policy and procedures, the facility failed to ensure that one resident (#51) received care and services, consistent with professional standards of practice, to prevent, treat, and/or heal a pressure ulcer. The sample size was 20. The deficient practice could result in development, worsening, and/or infection of pressure ulcers.
Findings include:
Resident #51 admitted to the facility 12/20/21 with diagnoses including paroxysmal atrial fibrillation, hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease and rheumatoid arthritis.
The admission Nursing Review dated 12/20/21 at 4:16 p.m. revealed the resident had no pressure sores, and that his skin was intact.
Review of the Baseline Care Plan dated 12/20/21 at 4:44 p.m. included potential for skin breakdown/pressure ulcers due to decreased mobility and incontinence. However, no goal or interventions were identified in the plan of care.
A potential risk for pressure ulcer development care plan initiated on 01/09/22 related to immobility had a goal for the resident to have intact skin, free of redness, blisters or discoloration. Interventions included to follow facility policies/protocols for the prevention/treatment of skin breakdown.
A physician ' s order dated 01/27/22 included monitoring the reddened, blanchable area to the right hip every shift for prevention.
Review of the significant change MDS assessment dated [DATE] revealed the resident scored 7 on the brief interview for mental status, indicating severe cognitive impairment. He required extensive one-person physical assistance for most activities of daily living, including bed mobility, and he had no pressure ulcers/injuries.
A Skin & Wound Evaluation dated 02/02/22 revealed a facility acquired deep tissue injury (DTI) to the resident ' s right lateral thigh. The wound measured at 1.7 centimeters (cm) x 2.2 cm. The wound bed was described as epithelial, 100% of wound covered, surface intact. Additional care included alternating pressure mattress and pressure reduction wheelchair cushion, nutrition/dietary supplementation and assistance with repositioning every 2 hours and as needed (PRN).
Review of the potential risk for pressure ulcer development care plan dated 02/02/22 revealed an update to include a deep tissue injury to the resident ' s right thigh. The goal was for the resident ' s pressure ulcer to show signs of healing and remain free from infection. Interventions included to assess/record/monitor wound healing every week.
The dietary progress note dated 02/04/22 at 6:44 p.m. included that the resident received 4 ounces of oral nutritional supplements 4 times per day with 100% intake.The note indicated that current meal and supplement intakes combined appeared to be meeting the estimated energy needs for wound healing.
Review of the Treatment Administration Record dated February 1 through 4, 2022 revealed monitoring of the resident ' s right hip was completed as ordered.
A physician ' s order dated 02/05/22 included application of a hydropolymer, adhesive foam dressing to the right hip every day shift, every 3 days for DTI.
The February 5 through 17, 2022 TAR revealed dressings were applied per orders.
A follow-up Skin & Wound Evaluation was not completed until 02/18/22. The evaluation revealed a deteriorating unstageable pressure ulcer which measured 3.9 cm x 2.8 cm. The wound bed was described as 80% slough, with light serosanguineous exudate, the edges were noted as epithelialization with blanching and erythema of the surrounding tissue. Additional care remained the same. No revision of the care plan was identified.
Review of the February 2022 TAR revealed the order for application of a hydropolymer, adhesive foam dressing to the right hip every day shift, every 3 days for DTI was discontinued on 02/22/22, when the physician ' s order identified wound care to the resident ' s left hip.
A subsequent Skin & Wound Evaluation was not completed until 03/07/22, and revealed a deteriorating unstageable pressure ulcer measuring 4.6 cm x 2.3 cm, with 90% of the wound bed filled with slough. Light serosanguineous exudate was noted, with edges identified as epithelialization with blanching and erythema of the surrounding tissue. Additional care remained the same, with no revision to the plan of care.
Review of the March 2022 TAR revealed wound care was administered to the resident ' s left hip wound as ordered. No nursing documentation was identified for the resident ' s right thigh/hip wound.
The Skin & Wound Evaluation dated 03/18/22 included a deteriorating unstageable pressure ulcer measuring 4.2 cm x 2.6 cm x 0.5 cm with 100% of the wound bed filled with slough. The wound exhibited warmth, and no exudate was identified. Wound edges were defined as epithelialized and surrounding tissue identified as blanching.The periwound temperature was described as warm. Additional care remained the same.
A physician ' s order dated 03/21/22 included cephalexin capsule (antibiotic) 500 milligrams (mg): give 1 capsule two times a day for wound infection for 5 days.
An interview was conducted on 01/11/23 at 9:01 a.m. with the Assistant Director of Nursing/wound nurse (ADON/staff #109). She stated that pressure ulcer interventions include a pressure reduction mattress, and if the resident is at high risk for developing wounds an overlay will be ordered, pressure relieving boots and dietary review. She stated that the facility does not have a repositioning program. She stated that per policy and PRN, every resident will receive a pressure-reduction cushion. She stated that if the resident develops a pressure ulcer, the physician and the dietitian will be notified. She stated that the expectation is that the pressure ulcer/injury will be reviewed and documented weekly.
On 01/11/23 at 9:42 a.m. a follow-up interview was conducted with the ADON/wound nurse. She stated that the location of the wound was actually on the resident ' s right hip not thigh. She stated that she went on leave from March 2, 2022 through June 7 or 8, 2022. She stated that when she left the wound was a DTI, when she came back the wound was unstageable. She stated that someone in the facility was covering wound care and assessments on a weekly basis.
The Skin/Wound Care Protocol policy, reviewed 5/14, included the goal of a preventative skin program is to maintain skin integrity and provide guidelines for skin care. A licensed nurse completes a weekly skin assessment and documents the assessment on the Weekly Skin/Pain Assessment form.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0726
(Tag F0726)
Could have caused harm · This affected multiple residents
Based on personnel file review, staff interviews, and facility policy, the facility failed to ensure that two of two sampled Certified Nursing Assistants (CNA/staff #100 and #91) were able to demonstr...
Read full inspector narrative →
Based on personnel file review, staff interviews, and facility policy, the facility failed to ensure that two of two sampled Certified Nursing Assistants (CNA/staff #100 and #91) were able to demonstrate competencies and skills necessary to provide care for residents. The census was 80. The deficient practice could result in inadequate care for residents.
Findings include:
Review of a personnel file for a CNA (staff #100) revealed a hire date of 05/14/03, for hourly employment. The personnel record contained no evidence of a comprehensive evaluation for nursing skills and competencies for 2022.
Review of a personnel file for CNA/staff #91 revealed a hire date of 08/12/20, for hourly employment. The personnel record contained no evidence of a comprehensive evaluation for nursing skills and competencies for 2022.
On 01/11/23 at 12:52 p.m. an interview was conducted with the Staffing Coordinator (staff #1). She stated that staff are evaluated for skills upon hire. She stated that she was not sure how often CNAs are re-evaluated. She stated that Human Resources sends reports to department heads and that the department heads were responsible to ensure that staff completes training and is up to date.
An interview was conducted on 01/11/23 at 3:30 p.m. with the Clinical Resource Nurse (staff #117) and the Human Resource Director (staff #61). They stated that there had been no skills training for staff in 2022.
On 01/12/23 at 1:05 p.m. a follow-up interview was conducted with the Human Resource Director (staff #61). She stated that skills evaluations and training was missed in 2022 due to the impending transition [acquisition] by the new owners. She stated that staff competencies should be evaluated yearly and as needed.
An interview was conducted on 01/13/23 at 10:08 a.m. with the Director of Nursing (DON/staff #41). She stated that CNAs should receive skills training annually. She stated that the training was scheduled, but canceled. She stated that skills training was important to ensure staff competency to meet the needs of the residents.
The Employment Requirements/Verification of Skills policy, revised 1/18, included that an employee shall possess the specific skills and knowledge necessary to provide residents residing in the facility with the type of care and services necessary to support and respect each resident ' s individuality, choices, strengths and abilities.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Pharmacy Services
(Tag F0755)
Could have caused harm · This affected multiple residents
Based on observations, staff interviews, and policy review, the facility failed to ensure their system of medication records is complete to enable accurate reconciliation and accounting for all contro...
Read full inspector narrative →
Based on observations, staff interviews, and policy review, the facility failed to ensure their system of medication records is complete to enable accurate reconciliation and accounting for all controlled medications. The deficient practice could result in misappropriation of residents' medications.
Findings Include:
-Prior to medication pass observation conducted on January 11, 2023 at 8:26 a.m. with a licensed nurse (LPN/ staff #47), she was observed handed medication cards wrapped in the reconciliation sheets to the assistant director of nursing (ADON/staff #109). Staff #109 walked away with medication cards in her hands to another unit.
Following this observation, an interview was conducted with staff #47 on January 11, 2023 at 8:50 a.m. Staff #47 stated the medications that was given to staff #109 are narcotic medications of the residents that have been discharged or have their orders discontinued. Staff #47 stated that staff # 109 or the director of nursing (DON/ staff #41) picks up the discontinued controlled medications once a week or whenever they have a chance. Staff #47 stated she did not know where the discontinued narcotic drugs are stored, or where it goes.
An interview was conducted on January 11, 2023 at 9:00 a.m. with the DON (staff #41). The DON stated the process for the discontinued narcotic drugs included placing the narcotic drugs in a double locked safe in her office. During the narcotic medication destruction, the medications were placed in the red sharps container, then a bottle of Metamucil and water is added. She stated the red sharp container is placed in the red bag, then in the biohazard container.
A second interview was conducted on January 11. 2023 at 10:58 a.m. with staff #41. She stated the process when narcotic medications are discontinued included the licensed nurse handing her the medications. Staff #41 stated she does not sign any document that she received the discontinued medications, and that she did not have a process, the nurses just hands it to her and she takes it. Further, staff #41 stated how she ensure the discontinued narcotic medications taken from the cart was given to her is that she trusts her staff and that she has been doing this job for a long time. Staff #41 stated she does not sign for the discontinued narcotic drugs given to her, and that she trusts her staff.
On January 11, 2023 at 11:24 a.m., a joint review of the individual resident's-controlled substance record was conducted with the Federal Surveyor. The record review revealed that 14 of 65 sampled documents were incomplete.
An interview was conducted on January 12, 2023 at 7:34 a.m. with staff #47. She stated the process when narcotic drugs are delivered from the pharmacy included an electronic signature and a paper signature that serves as the courier's receipts. She stated the narcotic medications is placed in the narcotic cart, then the new narcotic is added in the narcotic proof of use count sheet, indicated with a plus sign. She stated if a narcotic medication is discontinued, she would remove the medication card and individual narcotic sheet and give it to the ADON (staff #109) for destruction. She stated the narcotic proof of use sheet is marked with a minus sign indicating the card was removed. She stated she cannot determine by looking at the record with a minus mark, whether the resident went home with the medications, or was given to the ADON for destruction because there was no signature who took the narcotics. Staff #47 reviewed the form and stated the form was incomplete. She stated it could put her nursing license in jeopardy because she has no way of knowing by looking at the record who took the narcotics. She reviewed the form and said the columns marked destroyed or transferred were left blanks therefore the form was incomplete.
Review of the facility form, Narcotic Proof of Use Count Sheet, dated December 13 through 31, 2022 revealed eight narcotic cards were removed from the narcotic cart. Further record review revealed that on January 1 through 5, 2023, three narcotic cards were removed from the narcotic cart.
However, there was no signature to determine who took the discontinued narcotic medications, and the columns on the form indicating the drug disposition (completed, destruction, transferred) were left blanks.
An interview was conducted with a registered nurse consultant (RN/staff #117) on January 12, 2023 at 2:11 p.m. Staff #117 reviewed the sampled form, Narcotic Proof of Use Count Sheet. After staff #117 completed the record review, she stated the chain of custody has insufficient details regarding the drug disposition.
Review of the facility policy, Disposal of Medications, dated 2007, stated discontinued medications and/or medications left in the in the nursing care center after a resident's discharge, which do not qualify for return to the pharmacy, are identified and removed from current medication supply in a timely manner for disposition. The policy stated medications included in the Drug Enforcement Administration (DEA) classification as controlled substances (or those classified as such by state regulation) are subject to special handling, storage, and record keeping in the nursing care center in accordance with federal and state laws. The policy included that if a controlled medication is unused, refused, by the resident or not given for any reason, it cannot be returned to the container; it is destroyed, and a controlled medication disposition log or equivalent form, shall be used for documentation and shall be retained as per Federal privacy and state regulations. The policy stated the log shall contain signature of the required witnesses (two licensed nurses employed by the nursing care center).
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Drug Regimen Review
(Tag F0756)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy and procedure, the facility failed to ensure five out of...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy and procedure, the facility failed to ensure five out of five residents (#32, #41, #14, #37, and #25) receiving psychotropic medications received consistent monitoring for behaviors and side effects. The facility census was 80. The deficient practice could result in unnecessary medication use and adverse side effects.
Findings include:
Resident #41 admitted to the facility on [DATE] with diagnoses including COVID 19, Alzheimer's disease with late onset, and dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance and anxiety.
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 06 on the Brief Interview for Mental Status (BIMS) assessment, indicating lack of cognition.
A review physician order:
Lexapro tablet 10 mg, give 1 tablet by mouth for depression ordered on 10/13/21
Lorazepam tablet 0.5mg, give 2 tablets by mouth every 4 hours as needed for anxiety for the duration of hospice. Ordered on 10/7/22.
Olanzapine tablet 5mg, give 1 tablet by mouth in the evening for dementia with behaviors. Ordered on 9/7/22.
Quetiapine furmarate tablet 50mg, give 1 tablet by mouth two times a say for dementia with behaviors/agitation. Ordered on 11/9/22.
Trazadone HCI tablet 50mg, give 0.5 tablet by mouth two times a day for anxiety, agitation, insomnia. Ordered on 12/23/21.
A review of care plan initiated on 2/14/22 revealed the following: focus: risk for signs and symptoms of adverse behaviors such as yelling out, crying, agitation, restlessness, exit seeking, and hallucinations associated with diagnosis of dementia. Goal: will demonstrate acceptance of needed help without aggressive outburst. Intervention: administer medications as ordered. Monitor and document for side effects and effectiveness.
A review of care plan initiated 10/29/19 revealed the following: focus: is at risk for signs and symptoms of adverse effects of medication due to antidepressant use. Goal: will be free from discomfort or adverse reactions related to antidepressant therapy. Interventions: administer antidepressant medications as ordered by physician. Monitor and document side effects and effectiveness q-shift. Monitor/document/report PRN adverse reactions to antidepressant therapy.
A review of care plan initiated on 1/14/22 revealed the following: focus: risk for sign and symptoms of adverse effects of medication due to use of psychotropic medications for management of dementia and depression. Goal: will be/remain free of psychotropic drug related complications, including movement disorder, discomfort, hypotension, gait disturbance, constipation/impaction or cognitive/behavioral impairment. Resident will reduce the uses of psychotropic medication. Intervention: Administer psychotropic medications as ordered by physician. Monitor for side effects and effectiveness q-shift. Consult with pharmacy MD to consider dosage reduction when clinically appropriate at least quarterly. Monitor, document, report prn any adverse reactions of psychotropic medications.
Review of the October, November, and December 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
However, the clinical record did not include evidence of monitoring for side effects or effectiveness of the medication as well as adverse reactions.
On 01/11/23 at 8:41 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #6). She stated that adverse side effects and behaviors will show up on the electronic MAR (eMAR). She stated that would also document in the resident ' s progress notes. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that behavior monitoring should pop up on either the MAR or the Treatment Administration Record (TAR). She stated that she would want it to pop up so that she would be able to monitor whether or not the behaviors were new or unusual, and/or whether the medication was working. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that the risks of not monitoring behaviors would include that the resident may receive unnecessary medication.
An interview was conducted on 01/11/23 at 1:10 p.m. with the Director of Nursing (DON/staff #41). She stated that monitoring for psychotropic medications would include adverse side effects, AIMS and behaviors. She reviewed the resident ' s record and stated that there was no side effect monitoring. She stated that behaviors are documented under the Certified Nursing Assistant (CNA) tasks. She stated that the CNA ' s monitored the resident for behaviors including grabbing, hitting, kicking and pushing.
Resident #25 admitted to the facility on [DATE] with diagnoses including hyperlipidemia, hypothyroidism, and lower back pain.
The quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 13 on the Brief Interview for Mental Status (BIMS) assessment, indicating appropriate cognition.
Physician orders:
Escitalopram oxalate tablet 10mg, give 1 tablet by mouth in the morning for anxiety/agitation. Ordered on 3/18/22.
Lorazepam tablet 0.5mg, give 1 tablet by mouth every 6 hours as needed for agitation for duration of hospice. Ordered on 10/7/22.
Lorazepam 1 tablet 1mg, give 1 tablet by mouth at bedtime for anxiety. Ordered on 11/12/22.
Quetiapine fumarate tablet 50mg, give 1 tablet by mouth three times a day for behaviors. Ordered on 3/18/22.
A review of care plan initiated on 4/8/22: focus: uses psychotropic medications due to dementia with hallucinations. Goal: will remain free of psychotropic drug related complications, including movement disorder, discomfort, hypotension, gait disturbance, constipation/impaction or cognitive/behavioral impairment. Interventions: administer psychotropic medications as ordered by physician. Monitor for side effects and effectiveness q-shift. Review behaviors and interventions and alternate therapies attempted and their effectiveness. Monitor, document, and report PRN any adverse reactions of psychotropic medications.
Review of the October, November, and December 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
However, the clinical record did not include evidence of monitoring for side effects or effectiveness of the medication as well as adverse reactions.
Based on review of the clinical record , staff interviews and review of the facility policy, the facility failed to ensure the pharmacist identified adequate monitoring for the use of medications in the pharmacy review for 5 residents (#32,#14,#37, #41 and #25). The deficient practice could allow for medication side effects and adverse consequences to go unadressed.
Findings include:
Regarding Resident #14-
Resident #14 was admitted [DATE] with diagnoses to include the primary diagnosis of Covid 19 and other diagnoses of schizoaffective disorder bipolar type, bipolar II disorder, generalized anxiety disorder, major depressive disorder and dementia with other behavior disturbance.
In the care plan initiated March 14, 2019, a focus area revealed that the resident had a behavior problem and interventions included to administer medications as ordered and to monitor for effectiveness and side effects. The care plan further revealed that the resident received antidepressant medication and psychotropic medication and side effects and medication effectiveness were to be monitored and documented every shift.
The minimum data set ( MDS) dated [DATE] revealed that the resident scored a 5 on the brief interview for mental status (BIMS) indicating severe cognitive impairment.
Review of the active orders revealed the following:
- 12/22/2022 Olanzapine 5 mg.( milligrams) 1.5 tablets at bedtime for schizoaffective disorder.
-12/19/2022 Divalproex Sodium delayed release 125 mg- give 250 mg by mouth two times a day for schizoaffective disorder and mood stability
- 12/02/ 2022 Sertraline HCL 100 mg tablet in the morning for depression
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found. No evidence of pharmacy recommendations monitoring were found in the clinical record.
Review of the December 2022 and January 2023 medication administration record (MAR) and treatment administration record (TAR) revealed that the medications were given as ordered. No evidence of monitoring for effectiveness or side effects were found.
- Regarding Resident #31
Resident #31 was admitted [DATE] with diagnoses to include recurrent depressive disorder and chronic pain syndrome.
Review of the residents care plan initiated on May 9, 2022 revealed the the resident had a behavior problem as evidenced by verbal aggression. An intervention for this issue was to monitor for behaviors and attempt to determine the underlying cause. This information was to be documented.
The care plan further revealed that the resident was prescribed anti depressant medication and the interventions included that changes in mood and behavior were to be documented. The resident also received an anti anxiety medication that included an intervention of monitoring of side effects and effectiveness.
The resident scored a 6 revealing severe cognitive impairment on the brief interview for mental status(BIMS) on the Quarterly minimum data set (MDS) dated [DATE]. 2022.
Review of the active orders revealed the following:
- 10/5/2022 Mirtazipine Tablet 15 mg(milligrams) at bedtime for depression
- 4/5/2022 Cymbalta 30 mg in the morning for depression, 8/15/2022 60 mg at bedtime for chronic pain
- 5/2/2022 Lorazapam 0.5 mg every 2 hours as needed for agitation
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found. No evidence was found of pharmacy recommendations for monitoring of side effects or effectiveness in the clinical record.
Review of the November, December 2022 and January 2023 medication administration record ( MAR) and treatment administration record (TAR) revealed the the medications were given as ordered. No evidence of monitoring for effectiveness and side effects were found.
- Regarding Resident #37
Resident#37 was admitted [DATE] with diagnoses to include recurrent major depressive disorder and primary insomnia.
Review of the residents care plan initiated on March 22, 2021 revealed that the resident used an antidepressant medication related to insomnia and depression. The listed interventions included monitor and document side effects and effectiveness every shift.
The quarterly Minimum Data Set, dated [DATE] revealed that the resident scored 15 on the brief interview for mental status ( BIMS) indicating that the resident was cognitively intact.
Review of the active orders revealed :
- 12/29/2022 Remeron 7.5 mg. ( milligrams) by mouth at bedtime for depression.
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found
Review of the October, November, December 2022 and January 2023 medication administration record ( MAR) and treatment administration record (TAR) revealed the the medications were given as ordered. No evidence of monitoring for effectiveness or side effects were found.
An interview was conducted with the facility medical director( staff #120) on January 13, 2023 at 11:21 am. He stated that he had been medical director for many years and had worked closely with staff. He stated that it was most important to monitor a resident when the resident first starts a new medication. He stated that as far as psychotropic's, things have changed over time. At this time, residents are monitored but residents were monitored more frequently previously. Staff #120 stated that if a resident is stable on a psychotropic medication it may be less critical to monitor every shift than to monitor someone displaying behaviors. Resident's psychotropic's are addressed and reviewed in the quarterly QAPI meetings. He stated that the staff were expected at convey any changes to him as well as what he observes himself during his visits. He stated that residents needs do change as they age and he was available for assessments as needed and he also works with attending physicians and pharmacists as needed. Staff #120 stated if there is a regulation requirement to document the monitoring, those changes can be made, as the facility makes an attempt to do things correctly and to meet the regulations.
At 11:53 AM on January 13, 2023 an interview was conducted with pharmacist ( staff #118), Head pharmacist ( staff #119) and the director of nursing (DON / staff #41) -Staff #118 stated that as far as side effects or behavior monitoring the staff mainly rely on the the resident self reports They do also look at the residents clinical record and will look at the resident as a whole person. Staff # 119 stated that per regulations, monitoring is not required to be on a set schedule. He further stated that it was not a requirement to monitor for behaviors on a resident that receives an anti-depressant. Staff #119 stated that they, as pharmacists do not make recommendations to nursing.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy and procedure, the facility failed to ensure five out of...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, staff interviews, and review of policy and procedure, the facility failed to ensure five out of five residents (#32, #41, #14, #37, and #25) receiving psychotropic medications received consistent monitoring for behaviors and side effects. The facility census was 80. The deficient practice could result in unnecessary medication use and adverse side effects.
Findings include:
Resident #41 admitted to the facility on [DATE] with diagnoses including COVID 19, Alzheimer's disease with late onset, and dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance and anxiety.
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 06 on the Brief Interview for Mental Status (BIMS) assessment, indicating lack of cognition.
A review physician order:
Lexapro tablet 10 mg, give 1 tablet by mouth for depression ordered on 10/13/21
Lorazepam tablet 0.5mg, give 2 tablets by mouth every 4 hours as needed for anxiety for the duration of hospice. Ordered on 10/7/22.
Olanzapine tablet 5mg, give 1 tablet by mouth in the evening for dementia with behaviors. Ordered on 9/7/22.
Quetiapine furmarate tablet 50mg, give 1 tablet by mouth two times a say for dementia with behaviors/agitation. Ordered on 11/9/22.
Trazadone HCI tablet 50mg, give 0.5 tablet by mouth two times a day for anxiety, agitation, insomnia. Ordered on 12/23/21.
A review of care plan initiated on 2/14/22 revealed the following: focus: risk for signs and symptoms of adverse behaviors such as yelling out, crying, agitation, restlessness, exit seeking, and hallucinations associated with diagnosis of dementia. Goal: will demonstrate acceptance of needed help without aggressive outburst. Intervention: administer medications as ordered. Monitor and document for side effects and effectiveness.
A review of care plan initiated 10/29/19 revealed the following: focus: is at risk for signs and symptoms of adverse effects of medication due to antidepressant use. Goal: will be free from discomfort or adverse reactions related to antidepressant therapy. Interventions: administer antidepressant medications as ordered by physician. Monitor and document side effects and effectiveness q-shift. Monitor/document/report PRN adverse reactions to antidepressant therapy.
A review of care plan initiated on 1/14/22 revealed the following: focus: risk for sign and symptoms of adverse effects of medication due to use of psychotropic medications for management of dementia and depression. Goal: will be/remain free of psychotropic drug related complications, including movement disorder, discomfort, hypotension, gait disturbance, constipation/impaction or cognitive/behavioral impairment. Resident will reduce the uses of psychotropic medication. Intervention: Administer psychotropic medications as ordered by physician. Monitor for side effects and effectiveness q-shift. Consult with pharmacy MD to consider dosage reduction when clinically appropriate at least quarterly. Monitor, document, report prn any adverse reactions of psychotropic medications.
Review of the October, November, and December 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
However, the clinical record did not include evidence of monitoring for side effects or effectiveness of the medication as well as adverse reactions.
On 01/11/23 at 8:41 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #6). She stated that adverse side effects and behaviors will show up on the electronic MAR (eMAR). She stated that would also document in the resident ' s progress notes. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that behavior monitoring should pop up on either the MAR or the Treatment Administration Record (TAR). She stated that she would want it to pop up so that she would be able to monitor whether or not the behaviors were new or unusual, and/or whether the medication was working. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that the risks of not monitoring behaviors would include that the resident may receive unnecessary medication.
An interview was conducted on 01/11/23 at 1:10 p.m. with the Director of Nursing (DON/staff #41). She stated that monitoring for psychotropic medications would include adverse side effects, AIMS and behaviors. She reviewed the resident ' s record and stated that there was no side effect monitoring. She stated that behaviors are documented under the Certified Nursing Assistant (CNA) tasks. She stated that the CNA ' s monitored the resident for behaviors including grabbing, hitting, kicking and pushing.
Resident #25 admitted to the facility on [DATE] with diagnoses including hyperlipidemia, hypothyroidism, and lower back pain.
The quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 13 on the Brief Interview for Mental Status (BIMS) assessment, indicating appropriate cognition.
Physician orders:
Escitalopram oxalate tablet 10mg, give 1 tablet by mouth in the morning for anxiety/agitation. Ordered on 3/18/22.
Lorazepam tablet 0.5mg, give 1 tablet by mouth every 6 hours as needed for agitation for duration of hospice. Ordered on 10/7/22.
Lorazepam 1 tablet 1mg, give 1 tablet by mouth at bedtime for anxiety. Ordered on 11/12/22.
Quetiapine fumarate tablet 50mg, give 1 tablet by mouth three times a day for behaviors. Ordered on 3/18/22.
A review of care plan initiated on 4/8/22: focus: uses psychotropic medications due to dementia with hallucinations. Goal: will remain free of psychotropic drug related complications, including movement disorder, discomfort, hypotension, gait disturbance, constipation/impaction or cognitive/behavioral impairment. Interventions: administer psychotropic medications as ordered by physician. Monitor for side effects and effectiveness q-shift. Review behaviors and interventions and alternate therapies attempted and their effectiveness. Monitor, document, and report PRN any adverse reactions of psychotropic medications.
Review of the October, November, and December 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
However, the clinical record did not include evidence of monitoring for side effects or effectiveness of the medication as well as adverse reactions.
- Regarding Resident # 14-
Resident #14 was admitted [DATE] with diagnoses to include the primary diagnosis of Covid 19 and other diagnoses of schizoaffective disorder bipolar type, bipolar II disorder, generalized anxiety disorder, major depressive disorder and dementia with other behavior disturbance.
In the care plan initiated March 14, 2019, a focus area revealed that the resident had a behavior problem and interventions included to administer medications as ordered and to monitor for effectiveness and side effects. The care plan further revealed that the resident received antidepressant medication and psychotropic medication and side effects and medication effectiveness were to be monitored and documented every shift.
The minimum data set ( MDS) dated [DATE] revealed that the resident scored a 5 on the brief interview for mental status (BIMS) indicating severe cognitive impairment.
Review of the active orders revealed the following:
- 12/22/2022 Olanzapine 5 mg.( milligrams) 1.5 tablets at bedtime for schizoaffective disorder.
-12/19/2022 Divalproex Sodium delayed release 125 mg- give 250 mg by mouth two times a day for schizoaffective disorder and mood stability
- 12/02/ 2022 Sertraline HCL 100 mg tablet in the morning for depression
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found.
Review of the December 2022 and January 2023 medication administration record ( MAR) and treatment administration record (TAR) revealed that the medications were given as ordered. No evidence of monitoring for effectiveness or side effects were found.
- Regarding Resident #31
Resident #31 was admitted [DATE] with diagnoses to include recurrent depressive disorder and chronic pain syndrome.
Review of the residents care plan initiated on May 9, 2022 revealed the the resident had a behavior problem as evidenced by verbal aggression. An intervention for this issue was to monitor for behaviors and attempt to determine the underlying cause. This information was to be documented.
The care plan further revealed that the resident was prescribed anti depressant medication and the interventions included that changes in mood and behavior were to be documented. The resident also received an anti anxiety medication that included an intervention of monitoring of side effects and effectiveness.
The resident scored a 6 revealing severe cognitive impairment on the brief interview for mental status(BIMS) on the Quarterly minimum data set (MDS) dated [DATE]. 2022.
Review of the active orders revealed the following:
- 10/5/2022 Mirtazipine Tablet 15 mg(milligrams) at bedtime for depression
- 4/5/2022 Cymbalta 30 mg in the morning for depression, 8/15/2022 60 mg at bedtime for chronic pain
- 5/2/2022 Lorazapam 0.5 mg every 2 hours as needed for agitation
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found.
Review of the November, December 2022 and January 2023 medication administration record ( MAR) and treatment administration record (TAR) revealed the the medications were given as ordered. No evidence of monitoring for effectiveness and side effects were found.
- Regarding Resident #37
Resident#37 was admitted [DATE] with diagnoses to include recurrent major depressive disorder and primary insomnia.
Review of the residents care plan initiated on March 22, 2021 revealed that the resident used an antidepressant medication related to insomnia and depression. The listed interventions included monitor and document side effects and effectiveness every shift.
The quarterly Minimum Data Set, dated [DATE] revealed that the resident scored 15 on the brief interview for mental status ( BIMS) indicating that the resident was cognitively intact.
Review of the active orders revealed :
- 12/29/2022 Remeron 7.5 mg. ( milligrams) by mouth at bedtime for depression.
-No evidence of orders for monitoring for side effects or effectiveness of these drugs were found
Review of the October, November, December 2022 and January 2023 medication administration record ( MAR) and treatment administration record (TAR) revealed the the medications were given as ordered. No evidence of monitoring for effectiveness or side effects were found.
An interview was conducted with certified nursing assistant ( CNA/ staff #94) on January 11, 2023 at 2:03 pm. She stated that the CNAs will chart in the CNA charting and make the nurses aware of any behavior concerns so it can de documented in a progress note. She stated that all the residents in the secured unit are monitored for behaviors related to their diagnoses but the monitoring is not related to medications.
An interview with the director of nursing (DON/ staff #41) was conducted on January 11, 2023 at 2:10 pm. She stated that the facility does not monitor and has never monitored routine psychotropic's. She stated that the physicians do their own monitoring.
Based on clinical record review, staff interviews, and review of policy and procedure, the facility failed to ensure five out of five residents (#32, #41, #14, #37, and #25) receiving psychotropic medications received consistent monitoring for behaviors and side effects. The facility census was 80. The deficient practice could result in unnecessary medication use and adverse side effects.
Findings include:
-Resident #32 admitted to the facility on [DATE] with diagnoses including chronic respiratory failure with hypoxia, chronic obstructive pulmonary disease and post traumatic seizures.
An Abnormal Involuntary Movement Scale (AIMS) dated 11/17/22 revealed a score of Not Applicable (NA).
The admission Minimum Data Set (MDS) assessment dated [DATE] revealed the resident scored 15 on the Brief Interview for Mental Status (BIMS) assessment, indicating intact cognition. The resident reported no feelings of depression, and he displayed no symptoms of psychosis or behaviors.
A physician ' s order dated 11/30/22 revealed quetiapine fumarate (antipsychotic) 25 mg (milligrams): give one tablet at bedtime for traumatic brain injury (TBI).
No specific target behaviors related to TBI were identified in the order.
Review of the November 30 through December 6, 2022 Medication Administration Record (MAR) revealed the medication was administered in accordance with the physician ' s order.
A psychotropic medication care plan dated 12/06/22 related to TBI had a goal for the resident to be/remain free from psychotropic drug-related complications. Interventions included to administer psychotropic medications as ordered by the physician. Monitor for side effects and effectiveness every shift.
However, the clinical record did not include evidence of monitoring for side effects or effectiveness of the medication as evidenced by decreased episodes of target behaviors had been completed.
Another physician ' s order dated 12/12/22 included fluoxetine HCl (antidepressant) 20mg: give one capsule by mouth in the morning for depression.
Review of the December 2022 MAR revealed the resident received psychotropic medications in accordance with the physician ' s orders.
However, review of the clinical record did not indicate monitoring for side effects or effectiveness of the medication as evidenced by decreased episodes of target behaviors had been completed.
On 01/11/23 at 8:41 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #6). She stated that adverse side effects and behaviors will show up on the electronic MAR (eMAR). She stated that would also document in the resident ' s progress notes. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that behavior monitoring should pop up on either the MAR or the Treatment Administration Record (TAR). She stated that she would want it to pop up so that she would be able to monitor whether or not the behaviors were new or unusual, and/or whether the medication was working. She reviewed the resident ' s orders and stated that she did not see behavior monitoring. She stated that the risks of not monitoring behaviors would include that the resident may receive unnecessary medication. She reviewed the resident ' s record and stated that adverse side effects were not being monitored. She stated that the risks of not monitoring for adverse side effects might include falls, risks to self or others, or that nursing may not be aware of adverse effects.
An interview was conducted on 01/11/23 at 1:10 p.m. with the Director of Nursing (DON/staff #41). She stated that monitoring for psychotropic medications would include adverse side effects, AIMS and behaviors. She reviewed the resident ' s record and stated that there was no side effect monitoring. She stated that behaviors are documented under the Certified Nursing Assistant (CNA) tasks. She stated that the CNA ' s monitored the resident for behaviors including grabbing, hitting, kicking and pushing. She stated that the resident was receiving an antipsychotic for TBI. She stated that the provider had documented that the resident was receiving the antipsychotic for insomnia related to the TBI in one of her notes. She stated that the resident was not being monitored for insomnia/hours of sleep. She stated that the resident was receiving fluoxetine for depression, but that they had never monitored for depression.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0790
(Tag F0790)
Could have caused harm · This affected multiple residents
Based on clinical record review, resident and staff interviews, and policy, the facility failed to ensure that one resident (#54) was assisted in obtaining routine dental care. The sample size was 20....
Read full inspector narrative →
Based on clinical record review, resident and staff interviews, and policy, the facility failed to ensure that one resident (#54) was assisted in obtaining routine dental care. The sample size was 20. The deficient practice could result in residents ' dental needs not being met.
Findings include:
Resident #54 admitted to the facility 07/06/21 with diagnoses that included Alzheimer ' s disease with late onset, dementia in other diseases classified elsewhere, without behavioral, psychotic, or mood disturbance and major depressive disorder, recurrent, in remission.
Review of the admission Nursing Review dated 07/06/21 revealed the resident had no missing, broken, obvious or likely cavity or broken natural teeth.
An activities of daily living self-care performance deficit care plan dated 08/03/21 related to dementia with behaviors had a goal to maintain current level of function. Interventions included supervision/limited assistance with personal hygiene and oral care.
A physician ' s order dated 12/09/21 included acetaminophen (analgesic) 500 milligrams (mg). Give 500 mg every 6 hours as needed for pain of 1-5 on a pain scale; give 1000 mg for pain of 6-10.
However, additional review of the physician ' s orders did not indicate that a referral for routine dental care had been ordered and/or was being performed.
Review of the September 2022 Medication Administration Record (MAR) revealed acetaminophen was administered per orders for pain levels ranging from 4 to 7. However, a review of electronic MAR (eMAR) notes did not indicate the location of her pain. Further review of the pain scales revealed a general pain level of 0.
A physician ' s order dated 10/13/22 included acetaminophen 325 mg. Give 2 tablets two times a day for generalized pain.
Review of the October 2022 MAR revealed acetaminophen was administered in accordance with physician ' s orders. The pain scales indicated that the resident ' s pain was generally 0. Review of the as needed (PRN) administration of acetaminophen included pain levels of 3-6.
A Pain Evaluation was conducted on 11/08/22 at 1:23 p.m. According to the evaluation, the resident was able to interview and that she reported rarely experiencing pain over the past 5 days.
The November 2022 MAR included twice daily administration of acetaminophen per physician ' s orders. The pain scales revealed a general pain level of 0. PRN acetaminophen was administered on 11/24/22 for a pain level of 7.
The December 2022 MAR revealed acetaminophen was administered twice daily for generalized pain. Pain scales included a general pain level of 0, and PRN acetaminophen was not administered.
On 01/09/23 at 11:01 a.m. an interview was conducted with the resident ' s representative. The representative expressed concern regarding the resident ' s dental issues, including missing caps in front, and the need for her to see a dentist.
A physician progress note dated 01/09/23 at 1:12 p.m. included that upon the visit, the resident reported feeling so so. The note indicated that the resident appeared calm and pleasant, and that she was observed to have poor dentition.
On 01/11/23 at 8:06 a.m. an observation of the resident was conducted. The resident was noted to have black/brown broken remnants and missing teeth. She was observed to display a nearly continuous sucking motion with her mouth when not speaking.
At 8:06 a.m. on 01/11/23 an interview was conducted with the resident with a Spanish-speaking interpreter/Certified Nursing Assistant (CNA/staff #82). Staff #82 stated that the resident was very hard of hearing and that she read lips. She stated that she communicates with the resident by coming close to her face so the resident can see her lips and by speaking loudly. The resident stated her teeth hurt a lot.
On 01/12/23 at 11:37 a.m. an interview was conducted with a Licensed Practical Nurse (LPN/staff #97). She stated that the resident shows her where her pain is. She stated that she will ask the resident what her pain level is and the resident usually states 3 or 4. She stated that otherwise, she will observe the resident ' s appearance. She stated that she asks how bad the pain is, but that the resident does not always provide a number. She stated that the resident primarily complains of pain in her ear. She stated that acetaminophen has been ordered for scheduled administration. She stated that administration of the medication is preventative. She stated that she visually assesses the resident ' s pain using the Pain Assessment in Advanced Dementia Scale (PAINAD) and that she does not always ask her what her pain level is.
At 11:43 a.m. on 01/12/23 with the assistance of an interpreter, the resident was asked what her pain level was. The resident stated that on a scale of 1-10, her pain was a 10. She stated that sometimes some of her teeth hurt, other times they all hurt. She stated that her pain was great. She stated that she would like to see a dentist so that she can feel better.
An interview was conducted on 01/12/23 at 1:58 p.m. with the Director of Nursing (DON/staff #41). She stated that the resident did not complain of pain. She stated that the resident did not indicate that her teeth hurt. She stated that the resident is able to communicate when she has pain. She stated that the resident did not complain of tooth pain.
On 01/13/23 at 8:59 a.m. an interview was conducted with the Director of Social Services (staff #54). She stated that the unit secretary schedules appointments. She stated that if mobile specialists were coming into the facility, and the nurse makes her aware, she will make sure the resident gets an appointment. She stated that ultimately, she was responsible to ensure that residents are getting annual hearing, dental and vision appointments. She stated that if an emergent situation were to arise, she would also arrange an appointment as needed. She stated that if the residents were not getting their appointments it would be because either she had not set one up or the resident had refused. She stated that the lack of dental services had been an error on her part.
The Dental Services policy, revised December 2016, included that routine and emergency dental services are available to meet the resident ' s oral health services in accordance with the resident ' s assessment and plan of care. Routine and 24-hour emergency dental services are provided to residents through a contract agreement with a licensed dentist that comes to the facility monthly, referral to the resident ' s personal dentist, referral to community dentists and referral to other healthcare organizations that provide dental services. Social services representatives will assist residents with their appointments, transportation agreements, and for reimbursement of dental services under the state plan, if eligible. All dental services provided are recorded in the resident ' s medical record.